Shiozaki Manabu, Torii Sho, Sato Yu, Aihara Kazuki, Matsumoto Yuki, Nakamura Norihito, Suzuki Daiki, Ikari Yuji, Nakazawa Gaku
Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Department of Cardiology, Kindai University Faculty of Medicine, Osaka, Japan.
Catheter Cardiovasc Interv. 2025 Jun;105(7):1656-1663. doi: 10.1002/ccd.31505. Epub 2025 Mar 20.
Drug-coated balloon (DCB) are effective treatment options for patients with coronary artery disease and using of scoring or cutting balloon before the DCB usage were recommended. However, the effectiveness of lesion preparation with cutting balloons (CB) followed by DCB (CB + DCB) has not been evaluated before.
The aim of the current study was to compare the biological effect of various types of balloon angioplasty in a healthy rabbit iliac artery model.
Each of the four kinds of treatments as balloon angioplasty (BA), CB alone, DCB alone, and CB + DCB were performed in the healthy iliac arteries of 12 rabbits, which were euthanized after 14 days. The treated iliac arteries were sequentially cut, stained with hematoxylin and eosin and Movat Pentachrome, and histopathologically evaluated.
The depth of medial smooth muscle cell (SMC) loss score, an indicator of drug effect, was highest with CB + DCB, followed by DCB, CB, and BA (CB + DCB vs. DCB vs. CB vs. BA: 3.83 (3.67-4.00) vs. 3.17 (2.67-3.67), 1.67 (1.67-2.08) vs. 1.50 (1.00-1.67), p < 0.0001). The angle with severe SMC loss was also the highest with CB + DCB group, followed by DCB group, CB group, and BA group (123.7 (104.5-132.2) vs. 52.1 (34.7-100.6), 0.0 (0.0-14.2) vs. 0.0 (0.0-0.0), respectively, p < 0.0001), suggesting a higher drug effect in CB + DCB compared with DCB alone.
The drug effect of DCB was enhanced when CB was used before DCB treatment, suggesting the effectiveness of the combination therapy of CB and DCB.
药物涂层球囊(DCB)是治疗冠状动脉疾病患者的有效选择,推荐在使用DCB之前使用刻痕球囊或切割球囊。然而,此前尚未评估切割球囊(CB)预处理后再使用DCB(CB + DCB)的病变预处理效果。
本研究旨在比较在健康兔髂动脉模型中不同类型球囊血管成形术的生物学效应。
对12只兔子的健康髂动脉分别进行四种治疗,即单纯球囊血管成形术(BA)、单纯CB、单纯DCB以及CB + DCB,14天后对兔子实施安乐死。将处理后的髂动脉依次切开,进行苏木精-伊红染色和Movat五色染色,并进行组织病理学评估。
作为药物效果指标的中膜平滑肌细胞(SMC)损失深度评分,CB + DCB组最高,其次是DCB组、CB组和BA组(CB + DCB组 vs. DCB组 vs. CB组 vs. BA组:3.83(3.67 - 4.00) vs. 3.17(2.67 - 3.67),1.67(1.67 - 2.08) vs. 1.50(1.00 - 1.67),p < 0.0001)。严重SMC损失的角度也是CB + DCB组最高,其次是DCB组、CB组和BA组(分别为123.7(104.5 - 132.2) vs. 52.1(34.7 - 100.6),0.0(0.0 - 14.2) vs. 0.0(0.0 - 0.0),p < 0.0001),表明与单纯DCB相比,CB + DCB的药物效果更高。
在DCB治疗前使用CB可增强DCB的药物效果,提示CB与DCB联合治疗的有效性。